U.S. Pharma Stock News

Akero Therapeutics (AKRO) stock has caught the attention of investors after a recent upward move of 28% over the past month. The company has seen notable momentum lately, and this has prompted some to take a closer look at its performance. See our latest analysis for Akero Therapeutics. That strong 1-month share price return of 27.6% has put Akero Therapeutics back in the spotlight, especially after a year where the stock has surged 91.7% year-to-date and delivered a 72.4% total shareholder...

NIO (NYSE:NIO) shares have shown some swings in recent weeks, catching the attention of investors looking for opportunities in the electric vehicle space. The stock’s movement over the past month reflects the market’s ongoing debate about the company’s growth prospects. See our latest analysis for NIO. Over the past year, NIO’s share price has staged a sharp comeback, climbing more than 48% year-to-date after surging 54% in the last three months. However, the longer-term total shareholder...

Earlier this past week, United Airlines Holdings reported mixed third-quarter 2025 results, delivering an earnings per share beat while falling slightly short on revenue expectations and experiencing lower operating margins amid rising cost pressures. The company nevertheless issued a robust outlook for the fourth quarter and full year 2025, highlighting anticipated record revenue and continued investment in premium services and technology upgrades. Next, we'll review how United's ongoing...

Disc Medicine has caught the attention of investors after it announced receipt of a Commissioner's National Priority Voucher from the FDA for its investigational drug bitopertin in erythropoietic protoporphyria, a rare and challenging condition. See our latest analysis for Disc Medicine. Disc Medicine’s shares have caught fire, jumping more than 40% in the past month alone and rising 77.89% on a one-year total return basis. The FDA voucher news has significantly boosted momentum, adding to...

Earlier in October 2025, CBRE Group reported that office leasing activity in New York City surged significantly above the five-year average, with leasing volume reaching 8.36 million square feet in the third quarter. In addition, several leadership changes and major client mandates, including the exclusive assignment for the sale of Valencia CF’s Mestalla land, emphasized CBRE’s ongoing role across key European and North American markets. This rebound in office leasing activity was driven by...

Amcor announced the appointment of Stephen R. Scherger as Chief Financial Officer, effective November 10, 2025, succeeding Michael Casamento, while also reaffirming its fiscal 2026 earnings guidance as previously outlined. The simultaneous leadership transition and the launch of AmSecure, a proprietary healthcare packaging innovation, mark significant steps toward operational development and market differentiation for Amcor. We'll examine how Stephen R. Scherger's arrival as CFO could impact...

Zymeworks (ZYME) has come into focus as investors anticipate preliminary Phase 1 results for its investigational therapy, ZW191. These results are set to be unveiled at a major industry conference next week. See our latest analysis for Zymeworks. After a quiet stretch earlier in the year, Zymeworks shares have shown impressive momentum, climbing nearly 16% over the past month and up 29% for the last quarter as enthusiasm builds for upcoming clinical results and recent leadership changes. Over...

Snap-on reported third-quarter 2025 results that surpassed Wall Street expectations, with sales rising to US$1.19 billion and net income reaching US$265.4 million, buoyed by strength in its Repair Systems & Information segment. A distinct insight from the announcement is the company’s improvement in operating margins and continued momentum in diagnostics and repair platforms, even as certain segments faced challenges and overall macroeconomic conditions remained uncertain. We’ll explore how...

First Industrial Realty Trust (FR) posted a net profit margin of 33.2%, a step down from last year's 47% margin. The five-year average annual earnings growth sits at 3.7%. Looking ahead, the company expects earnings to grow at 5.05% per year and revenue at 7.2% per year, both trailing the broader US market's expected growth. Investors will be closely watching how First Industrial balances profitability and growth in the face of ongoing margin pressures and a financial position flagged as a...

Helios Technologies recently experienced increased momentum in its industrial and health & wellness markets, driven by strong demand for quick-release coupling products alongside improved pricing, cost control, and operational efficiency. This combination of robust demand and operational execution has primed investor sentiment with heightened expectations ahead of the company’s upcoming quarterly earnings report. We'll explore how Helios Technologies' surge in demand for its quick-release...

Fitch Ratings recently upgraded Global Net Lease's corporate credit rating to investment-grade BBB-, citing the company’s substantial asset sales and strengthened balance sheet through debt reduction and refinancing activities. This credit rating upgrade highlights Global Net Lease's efforts to improve financial flexibility and long-term resilience despite ongoing challenges in its underlying portfolio. We’ll evaluate how this new investment-grade rating serves as a crucial inflection point...

Independent Bank (INDB) just released third-quarter results that outpaced expectations, with revenue climbing and net interest margin showing marked gains. The boost came largely from the recent Enterprise Bancorp acquisition, which increased both market presence and asset base. See our latest analysis for Independent Bank. Momentum around Independent Bank has picked up following its strong quarterly performance and recent acquisition. The share price has advanced by 4.8% year-to-date and...

Carrier Global (CARR) shares have seen their value slide over the past 3 months, with the stock down nearly 27%. This period included a mix of industry headwinds as well as shifting sentiment around capital goods companies. See our latest analysis for Carrier Global. While Carrier Global's 27% slide over the past three months grabs attention, it is part of a broader downward stretch, with a one-year total shareholder return of -30.24%. Despite short-term setbacks and a recent cooling in...

Danaos (NYSE:DAC) just closed a $500 million offering of 6.875% senior notes due 2032. This move essentially reshapes its debt profile and provides fresh flexibility for future business decisions. See our latest analysis for Danaos. The successful note sale comes shortly after a recent board refresh and a series of debt-related announcements, highlighting Danaos’ active approach to optimizing its capital structure. While the share price dipped 8.6% over the past month, longer-term momentum...

Federated Hermes (FHI) has just rolled out the Federated Hermes Enhanced Income ETF. The new fund targets investors seeking steady monthly cash flow along with a carefully balanced approach to risk management. This move signals the company's ongoing commitment to diversified income solutions. See our latest analysis for Federated Hermes. The rollout of the Enhanced Income ETF comes after a series of steady moves for Federated Hermes, including ongoing fund performance disclosures and growth...

Abbott Laboratories (ABT) issued third-quarter earnings that met profit expectations, while revenue came in just under consensus due to challenges in diagnostics and baby formula. The company maintained its full-year guidance and narrowed the range slightly. See our latest analysis for Abbott Laboratories. Shares of Abbott Laboratories slipped following Q3 results that aligned with profit forecasts but came in just shy on sales, with investors reacting to softer diagnostics and nutrition...

Chime Financial (CHYM) has drawn interest after analysts weighed in on a court ruling around debit interchange fees. The consensus is that, because of Chime’s partnerships with smaller banks, the company should see minimal direct impact from the ruling. See our latest analysis for Chime Financial. Chime Financial’s share price has seen steep declines in recent months, with a 1-month share price return of -27% and a year-to-date slide of nearly 54%. While concerns about the broader environment...

Jabil (JBL) delivered a net profit margin of 2.2% in the latest period, down from 4.8% the year before, driven by a significant $300 million one-off loss impacting recent financials. Revenue is projected to grow at 5.8% per year, lagging behind the broader US market's 10.1% pace. The company’s EPS is expected to jump 20.27% annually, surpassing the US market average of 15.6%. Despite margin pressure, analysts are looking for a rebound in profitability and the potential for Jabil’s strong...

Saba Capital Management’s recent open market purchases of ASA Gold and Precious Metals (NYSE:ASA), combined with board changes including Karen Caldwell’s appointment as Audit and Ethics Chair, are drawing extra attention from investors this month. See our latest analysis for ASA Gold and Precious Metals. This wave of insider buying and board refresh at ASA Gold and Precious Metals comes as momentum builds in its share price. The past month delivered a 19.65% share price return, while the...

Lululemon athletica (LULU) shares have managed a small gain over the past month, even as the stock has struggled year to date. Despite some ups and downs, investors are looking for cues on what might drive movement next. See our latest analysis for lululemon athletica. After a punishing drop earlier this year, lululemon athletica’s 1-month share price return has edged into positive territory, which hints at some stabilization. Still, momentum remains weak overall, with a 1-year total...

HEICO (HEI) has been on the radar for investors watching the capital goods sector, especially given its returns over the past three and five years. Although there is no immediate headline event, the recent data offers insight into its longer-term performance. See our latest analysis for HEICO. HEICO’s share price has held relatively steady in recent weeks after a strong year-to-date climb of 29.43%. Its one-year total shareholder return of 17.77% continues to reflect long-term growth...

Open Text (NasdaqGS:OTEX) is making headlines after announcing a strategic Memorandum of Understanding with Core42 to accelerate AI and cloud solutions for the UAE’s public sector. The move highlights Open Text’s expanding global reach and technology leadership. See our latest analysis for Open Text. Momentum has been building for Open Text, with the stock posting a 6.35% share price return over the past month and a standout 38.16% gain year-to-date. Alongside major partnerships like the...

Vulcan Materials (VMC) shares have risen just over 1% in the past month, catching investor interest as traders consider the company’s recent performance and outlook. The building materials supplier has also posted steady annual revenue and profit growth. See our latest analysis for Vulcan Materials. Vulcan Materials has quietly built momentum, with a 1-month share price return of 1.1% and a strong 15.6% gain so far this year. That positive trend is also evident in its total shareholder...

Pacific Biosciences of California (PACB) is in the spotlight after unveiling its SPRQ-Nx sequencing chemistry. This move lowers sequencing costs and enhances its Revio and Vega platforms with new features. See our latest analysis for Pacific Biosciences of California. There’s been a noticeable rebound in Pacific Biosciences’ share price lately, up 33% over the past month, as excitement builds around new features and large-scale project wins. However, looking at the bigger picture, the...